Akribion Therapeutics
Akribion Genomics discovers and develops groundbreaking CRISPR nucleases into a new class of genetics-based cancer therapies and advanced genome editing tools.
| Date | Investors | Amount | Round |
|---|---|---|---|
* | €8.0m | Seed | |
| Total Funding | 000k | ||
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads